83 FR 14855 - Healthcare Infection Control Practices Advisory Committee (HICPAC)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 83, Issue 67 (April 6, 2018)

In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Healthcare Infection Control Practices Advisory Committee (HICPAC). This meeting is open to the public; however, visitors must be processed in accordance with established federal policies and procedures. Attendance is limited only by room seating available, (add number of seats that will be available in the room). The public is also welcome to listen to the meeting via teleconference; 100 teleconference lines are available. Time will be available for public comment. The public is welcome to submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed below. The deadline for receipt of written public comment is May 3, 2018. All requests must contain the name, address, and organizational affiliation of the speaker, as well as the topic being addressed. Written comments should not exceed one single-spaced typed page in length and delivered in 3 minutes or less. Members of the public who wish to provide public comments should plan to attend the public comment session at the start time listed. Please note that the public comment period may end before the time indicated, following the last call for comments. Written comments received in advance of the meeting will be included in the official record of the meeting. Registration is required to attend in person or on the phone. Interested parties may register at www.cdc.gov/ hicpac.

[Federal Register Volume 83, Number 67 (Friday, April 6, 2018)]
[Notices]
[Page 14855]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-07050]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Healthcare Infection Control 
Practices Advisory Committee (HICPAC). This meeting is open to the 
public; however, visitors must be processed in accordance with 
established federal policies and procedures. Attendance is limited only 
by room seating available, (add number of seats that will be available 
in the room). The public is also welcome to listen to the meeting via 
teleconference; 100 teleconference lines are available. Time will be 
available for public comment. The public is welcome to submit written 
comments in advance of the meeting. Comments should be submitted in 
writing by email to the contact person listed below. The deadline for 
receipt of written public comment is May 3, 2018. All requests must 
contain the name, address, and organizational affiliation of the 
speaker, as well as the topic being addressed. Written comments should 
not exceed one single-spaced typed page in length and delivered in 3 
minutes or less. Members of the public who wish to provide public 
comments should plan to attend the public comment session at the start 
time listed. Please note that the public comment period may end before 
the time indicated, following the last call for comments. Written 
comments received in advance of the meeting will be included in the 
official record of the meeting. Registration is required to attend in 
person or on the phone. Interested parties may register at www.cdc.gov/hicpac.

DATES: The meeting will be held on May 17, 2018, 9:00 a.m. to 5:00 
p.m., EDT, and May 18, 2018, 9:00 a.m. to 12:00 p.m., EDT.

ADDRESSES: Centers for Disease Control and Prevention, Global 
Communications Center, Building 19, Auditorium B, 1600 Clifton Road NE, 
Atlanta, Georgia 30329 and teleconference at 866-692-3582, passcode: 
66783078.

FOR FURTHER INFORMATION CONTACT: Erin Stone, M.A., HICPAC, Division of 
Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE, 
Mailstop A-07, Atlanta, Georgia 30329, Telephone (404) 639-4045. Email 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Committee is charged with providing advice and 
guidance to the Director, Division of Healthcare Quality Promotion 
(DHQP), the Director, National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), the Director, CDC, and the Secretary, 
Health and Human Services, regarding (1) the practice of healthcare 
infection prevention and control; (2) strategies for surveillance, 
prevention, and control of infections, antimicrobial resistance, and 
related events in settings where healthcare is provided; and (3) 
periodic updating of CDC guidelines and other policy statements 
regarding prevention of healthcare-associated infections and 
healthcare-related conditions.
    Matters To Be Considered: The agenda will include updates on CDC's 
activities for prevention of healthcare-associated infections. It will 
also include updates from the following HICPAC workgroups: The 
Healthcare Personnel Guideline Workgroup; the National Healthcare 
Safety Network (NHSN) Workgroup; the Neonatal Intensive Care Unit 
(NICU) Guideline Workgroup; and the Products and Practices Workgroup. 
Agenda items are subject to change as priorities dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2018-07050 Filed 4-5-18; 8:45 am]
 BILLING CODE 4163-19-P